Fulford India jumps 20 pc on Merck & Co's delisting offer

Fulford India Ltd, a domestic subsidiary of Merck & Co Inc, jumped 20 per cent to its maximum daily limit, after it approved a delisting offer from its parent company

Merck is offering an indicative price of 1,150 rupees per share, a 67.7 percent premium to Fulford India's Friday's close, with the floor price set at 701.71 rupees, according to the BSE filing.

Merck & Co owns 74.95 percent stake in Fulford, and is looking to acquire the remaining 25.05 percent.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • With a saffron censor, freedom of filmmakers is in grave danger

    The composition of the Central Board of Film Certification (CBFC), recently reconstituted in the wake of the en bloc resignation of the previous panel

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Varun Dutt

<b>Riskfactor</b>: 'Fool'-filled method

The gambler’s fallacy, also known as the Monte Carlo fallacy, ...

Zehra Naqvi

Style must reflect a book’s content

Pakistani writer Bilal Tanweer talks about his book, The Scatter ...

Bubbles Sabharwal

Perfection is a myth

I meet a lot of young people in my line ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture